Par’s Off-Label Plea Deal Includes Clawback For Execs’ Pay In Case Of Future Misconduct

Par will pay $45 million for off-label promotion of Megace ES and enter a corporate integrity agreement that restricts incentive compensation for sales reps; the firm also drops its suit against FDA and removes descriptions of conversations with government officials from its court filings.